Search research articles
Contact Us
Filters
Showing results (31-40 of 206) with videos related to
Page
of 21
Sort By:
Blood
|
June 28, 2024
How I treat iron overload in adult MDS
Heather A Leitch, Rena Buckstein
Annals of Hematology
|
October 11, 2015
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
Erica Tsang, Heather A Leitch
Leukemia & Lymphoma
|
March 17, 2016
Pre- and post-treatment serum ferritin levels in patients with higher risk myelodysplastic syndromes receiving azacitidine
Erica Tsang, Heather A Leitch
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
Management of iron overload in adult myelodysplastic syndrome
Heather A Leitch, Rena Buckstein
British Journal of Haematology
|
November 17, 2017
Castleman disease: delineating the spectrum
Musa Alzahrani, Heather A Leitch
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
April 1, 1990
Structural analysis of the specific capsular polysaccharide of Rhodococcus equi serotype 1
R A Leitch, J C Richards
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 1, 1993
Validation of doubly labeled water for measurement of caloric expenditure in collegiate swimmers
P J Jones, C A Leitch
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 1, 2021
Mechanoredox Chemistry as an Emerging Strategy in Synthesis
Jamie A Leitch, Duncan L Browne
Chemical Society Reviews
|
October 18, 2017
Ruthenium-catalysed σ-activation for remote meta-selective C-H functionalisation
Jamie A Leitch, Christopher G Frost
Critical Reviews in Oncology/Hematology
|
May 31, 2021
Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
Cecilia H Kim, Heather A Leitch
Page
of 21
Search research articles
Search
Showing results (31-40 of 206) with videos related to
Sort By:
Page
of 21
Blood
|
June 28, 2024
How I treat iron overload in adult MDS
Heather A Leitch, Rena Buckstein
Annals of Hematology
|
October 11, 2015
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
Erica Tsang, Heather A Leitch
Leukemia & Lymphoma
|
March 17, 2016
Pre- and post-treatment serum ferritin levels in patients with higher risk myelodysplastic syndromes receiving azacitidine
Erica Tsang, Heather A Leitch
Hematology. American Society of Hematology. Education Program
|
December 5, 2025
Management of iron overload in adult myelodysplastic syndrome
Heather A Leitch, Rena Buckstein
British Journal of Haematology
|
November 17, 2017
Castleman disease: delineating the spectrum
Musa Alzahrani, Heather A Leitch
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
April 1, 1990
Structural analysis of the specific capsular polysaccharide of Rhodococcus equi serotype 1
R A Leitch, J C Richards
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 1, 1993
Validation of doubly labeled water for measurement of caloric expenditure in collegiate swimmers
P J Jones, C A Leitch
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
April 1, 2021
Mechanoredox Chemistry as an Emerging Strategy in Synthesis
Jamie A Leitch, Duncan L Browne
Chemical Society Reviews
|
October 18, 2017
Ruthenium-catalysed σ-activation for remote meta-selective C-H functionalisation
Jamie A Leitch, Christopher G Frost
Critical Reviews in Oncology/Hematology
|
May 31, 2021
Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae
Cecilia H Kim, Heather A Leitch
Page
of 21